S.G. Power Limited (PSX: SGPL) has approved a major 300 percent rights issue to raise funds for expansion into the healthcare and pharmaceutical sectors, according to a notification submitted to the Pakistan Stock Exchange.
The company’s board, in a meeting held on May 18, 2026, approved the issuance of 53.49 million ordinary shares at a par value of Rs. 10 each. The rights offering is expected to generate over Rs. 534 million in capital.
Under the proposal, shareholders will be offered approximately three new shares for every one share they currently hold, subject to approval from shareholders and regulatory clearance from the Securities and Exchange Commission of Pakistan.
The company stated that the capital raise is aimed at supporting its planned diversification into healthcare and related industries, marking a strategic shift in its long-term business direction.
Proceeds from the issue will be used to strengthen the company’s financial position, fund expansion initiatives, and improve overall equity structure, according to the filing.
Management added that key shareholders, including sponsors and directors, have committed to subscribing to their entitlement shares, while the remaining portion will be fully underwritten in line with regulatory requirements.
SG Power further said the move is expected to enhance financial flexibility and support more stable long-term returns as it expands beyond its core operations into new growth sectors.
